Rodman & Renshaw: Valeant Still Worth $118 Despite 'Soap Opera'
March 22, 2016 at 11:52 AM EDT
Raghuram Selvaraju of Rodman & Renshaw reiterated his bullish stance on Valeant Pharmaceuticals Intl Inc (NYSE: VRX), a day after ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.